[The rs4705342 gene mutation in the promoter region of the miR-143/ 145 cluster associated with the risk of prostate cancer in the Chinese Han population]

Zhonghua Nan Ke Xue. 2019 Aug;25(8):696-702.
[Article in Chinese]

Abstract

Objective: To explore the correlation between the rs4705342 gene mutation in the promoter region of the miR-143/ miR-145 cluster and the risk of PCa in the Chinese Han population.

Methods: We enrolled in this study 156 cases of PCa and 188 cancer-free controls. Using TaqMan SNP genotyping assay, we detected the polymorphism of rs4705342 in the promoter region of the miR-143/ miR-145 gene, and performed a stratified analysis on the family history of cancer, body mass index (BMI), age, smoking status, and alcohol consumption of the subjects.

Results: The proportion of family history of cancer was significantly higher in the case group than in the control (P = 0.01). No statistically significant differences, however, were found between the two groups in age (P = 0.32), BMI (P = 0.79), smoking status (P = 0.47), and alcohol consumption (P = 0.34), nor in the distribution of the TT, CT and CC genotypes (P = 0.07) except in that of the CC and TT/CT combined genotypes (P = 0.01). There were statistically significant differences in the distribution of CC and TT/CT combined genotypes between the non-smoking subgroups, (P = 0.02) and alcohol drinking subgroups (P = 0.03), but not between the clinical stages of PCa (P = 0.81) or the levels of PSA (P = 0.39).

Conclusions: The rs4705342 gene mutation in the promoter region of the miR-143/ miR-145 cluster is significantly associated with the pathogenesis of PCa in the Chinese Han population.

Keywords: Chinese Han population; genotyping; miR-143; miR-145; promoter region; prostate cancer; rs4705342; single nucleotide polymorphism.

MeSH terms

  • Asian People
  • Case-Control Studies
  • China
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • MicroRNAs / genetics*
  • Mutation
  • Polymorphism, Single Nucleotide
  • Promoter Regions, Genetic*
  • Prostatic Neoplasms / genetics*

Substances

  • MIRN143 microRNA, human
  • MIRN145 microRNA, human
  • MicroRNAs